You are here
Board of Directors
The Board of Directors is made up of 13 individuals—6 of whom are appointed by the Government of Canada—from a variety of backgrounds, each with a unique perspective and an understanding of the research world. The Directors are appointed for a three-year renewable term and bring with them expertise in the private, institutional, academic, research, and government sectors. One Director on the Board is a representative from one of the federal granting agencies.
The Board of Directors makes final decisions on projects to be funded and sets strategic objectives in the context of the funding agreement. It approves annual plans and objectives, and reviews the outcomes of these objectives each year. It regularly reviews issues from a risk-assessment perspective—determining what risks are acceptable and ensuring that appropriate mitigation steps are in place. As well, the Board sets the CFI’s overall compensation policy, and specifically sets compensation for management.
CFI Board of Directors
Kevin P. D. Smith, Chair
President and Chief Executive Officer, St. Joseph’s Healthcare Hamilton
Louise Proulx, Vice-Chair
Vice President, Product Development, Vertex Pharmaceuticals (Canada) Incorporated
Sheila A. Brown
Owner, HartsHill Educational Consulting Ltd.
Chairman & Chief Executive Officer, Ondine Biomedical Inc.
William R. Driedzic
Canada Research Chair in Marine Bioscience, Memorial University of Newfoundland
President and CEO, Medicure Inc.
Professor, School of Physical Therapy and Associate Dean College of Medicine,
University of Saskatchewan
Past President, TSX Venture Exchange
President and Chief Executive Officer, Montreal Economic Institute
Director, Lady Davis Research Institute, Jewish General Hospital
Gordon F. Stovel
Senior Financial Planning Advisor, Assante Financial Management Ltd.
Manager, Geological Services, Husky Energy